Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers. The N1 implant has already enabled paralyzed patients to control digital devices with their thoughts.
Founder & CEO
Series C Lead
Early Stage
Gold tier investors receive priority consideration for future clinical trials and experimental treatments.
Revenue share from BCI technology licensed to medical device manufacturers.
Contact Excession LLC to discuss investment opportunities